We are live on ! Find out more
AI

Axiom Investors Portfolio holdings

AUM $8.99B
1-Year Est. Return 44.68%
This Fund
S&P 500
This Quarter Est. Return
+8.34%
1 Year Est. Return
+44.68%
3 Year Est. Return
+214.21%
5 Year Est. Return
+302.8%
10 Year Est. Return
+1,834.44%
AUM
$4.17B
AUM Growth
+$271M
Cap. Flow
+$26.3M
Cap. Flow %
0.63%
Top 10 Hldgs %
40.61%
Holding
164
New
16
Increased
65
Reduced
54
Closed
26

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$88.3M
2
MELI icon
Mercado Libre
MELI
+$38.4M
3
HTHT icon
Huazhu Hotels Group
HTHT
+$31.9M
4
PYPL icon
PayPal
PYPL
+$31.5M
5
TCOM icon
Trip.com Group
TCOM
+$24.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 23.42%
2 Technology 18.03%
3 Financials 17.32%
4 Communication Services 12.99%
5 Industrials 7.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HDSN
101
Hudson Technologies
HDSN
$266M
$3.87M 0.09%
457,351
+124,511
+37% +$953K
MO icon
102
Altria Group
MO
$113B
$3.81M 0.09%
51,150
+42,550
+495% +$3.11M
HQY icon
103
HealthEquity
HQY
$8.75B
$3.64M 0.09%
72,985
+15,517
+27% +$726K
PRMW
104
DELISTED
Primo Water Corporation
PRMW
$3.53M 0.08%
278,123
+11,020
+4% +$137K
NVEE
105
DELISTED
NV5 Global
NVEE
$3.46M 0.08%
325,468
+67,028
+26% +$647K
SUM
106
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$3.43M 0.08%
122,489
+60,820
+99% +$1.58M
MNDT
107
DELISTED
Mandiant, Inc. Common Stock
MNDT
$3.4M 0.08%
+223,883
New +$3.18M
TAL icon
108
TAL Education Group
TAL
$6.67B
$3.39M 0.08%
166,200
JPM icon
109
JPMorgan Chase
JPM
$958B
$3.35M 0.08%
36,700
+10,000
+37% +$863K
KITE
110
DELISTED
Kite Pharma, Inc.
KITE
$2.89M 0.07%
27,914
+3,219
+13% +$263K
AMN icon
111
AMN Healthcare
AMN
$1.31B
$2.6M 0.06%
66,633
-25,720
-28% -$986K
PLCE icon
112
Children's Place
PLCE
$58.3M
$2.59M 0.06%
25,329
-10,482
-29% -$1.15M
WTFC icon
113
Wintrust Financial
WTFC
$11.1B
$2.53M 0.06%
33,067
-22,853
-41% -$1.64M
MWA icon
114
Mueller Water Products
MWA
$4.15B
$2.51M 0.06%
215,110
+32,210
+18% +$370K
NGVT icon
115
Ingevity
NGVT
$2.58B
$2.5M 0.06%
43,490
-27,155
-38% -$1.6M
MSCC
116
DELISTED
Microsemi Corp
MSCC
$2.39M 0.06%
50,994
-31,603
-38% -$1.55M
EVR icon
117
Evercore
EVR
$12.4B
$2.38M 0.06%
33,748
-36,981
-52% -$2.69M
YUMC icon
118
Yum China
YUMC
$16.5B
$2.35M 0.06%
59,655
+155
+0.3% +$5.59K
VNDA icon
119
Vanda Pharmaceuticals
VNDA
$319M
$2.19M 0.05%
134,653
+5,297
+4% +$76.3K
NVRO
120
DELISTED
NEVRO CORP.
NVRO
$2.13M 0.05%
28,682
-3,857
-12% -$309K
VCYT icon
121
Veracyte
VCYT
$3.7B
$2.06M 0.05%
247,545
+9,747
+4% +$79.5K
ACRS icon
122
Aclaris Therapeutics
ACRS
$820M
$1.9M 0.05%
70,108
+2,641
+4% +$71.8K
ADMS
123
DELISTED
Adamas Pharmaceuticals
ADMS
$1.76M 0.04%
+100,912
New +$1.67M
IMMU
124
DELISTED
Immunomedics Inc
IMMU
$1.74M 0.04%
196,873
+44,153
+29% +$310K
PCRX icon
125
Pacira BioSciences
PCRX
$1.05B
$1.74M 0.04%
36,424
+5,988
+20% +$278K

Similar funds

Axiom Investors's Q2 2017 Portfolio in Review

As of Q2 2017, Axiom Investors held 164 positions worth $4.17B, up 6.9% from $3.9B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Axiom Investors's Q2 2017 filing shows 16 new, 65 increased, 54 reduced and 26 closed positions. Its largest new stake was Mercado Libre: 149,317 shares worth $37.5M. The largest sale was Snap-on, an estimated $41.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • Axiom Investors's largest Q2 2017 buy was Mercado Libre: 149,317 shares worth $37.5M.
  • Axiom Investors added most to Alibaba in Q2 2017, an estimated $88.3M increase.
  • Axiom Investors's biggest Q2 2017 reduction was Meta Platforms (Facebook), cutting an estimated $29.1M.
  • Axiom Investors fully exited Snap-on in Q2 2017, selling an estimated $41.9M.
  • Axiom Investors's ten largest holdings make up 41% of its $4.17B portfolio in Q2 2017.
  • Axiom Investors opened 16 new positions and closed 26 in Q2 2017.
  • Axiom Investors's portfolio value rose 6.9% quarter-over-quarter to $4.17B.

Based on Axiom Investors's 13F filing for Q2 2017, filed 14 Aug 2017.